These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2360344)

  • 1. Danazol for Evan's syndrome due to SLE.
    Aranegui P; Giner P; Lopez-Gomez M; el Amrani A; Jimenez-Alonso J
    DICP; 1990 Jun; 24(6):641-2. PubMed ID: 2360344
    [No Abstract]   [Full Text] [Related]  

  • 2. [Danazol and autoimmune thrombocytopenia in systemic lupus erythematosus].
    Selva A; Jordana R; Tolosa C; Ordi J
    Med Clin (Barc); 1990 Apr; 94(14):557-8. PubMed ID: 2355774
    [No Abstract]   [Full Text] [Related]  

  • 3. Danazol for the treatment of refractory autoimmune thrombocytopenia in systemic lupus erythematosus.
    West SG; Johnson SC
    Ann Intern Med; 1988 May; 108(5):703-6. PubMed ID: 3358571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Danazol's failure to suppress autoimmunity in NZB/NZW F1 mice.
    Roubinian JR; Talal N; Greenspan JS; Goodman JR; Nussenzweig V
    Arthritis Rheum; 1979 Dec; 22(12):1399-1402. PubMed ID: 316328
    [No Abstract]   [Full Text] [Related]  

  • 5. Preliminary observations on danazol therapy of systemic lupus erythematosus: effects on DNA antibodies, thrombocytopenia and complement.
    Agnello V; Pariser K; Gell J; Gelfand J; Turksoy RN
    J Rheumatol; 1983 Oct; 10(5):682-7. PubMed ID: 6606038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperglucagonaemia and treatment with danazol for systemic lupus erythematosus.
    David J
    Br Med J (Clin Res Ed); 1985 Oct; 291(6503):1170-1. PubMed ID: 3931840
    [No Abstract]   [Full Text] [Related]  

  • 7. Danazol for lupus thrombocytopenia.
    Marino C; Cook P
    Arch Intern Med; 1985 Dec; 145(12):2251-2. PubMed ID: 4074040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of lupus-erythematosus-like disease with danazol.
    Masse R; Youinou P; Dorval JC; Cledes J
    Lancet; 1980 Sep; 2(8195 pt 1):651. PubMed ID: 6107447
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of danazol on lupus-erythematosus-like disease in hereditary angioneurotic oedema.
    Donaldson VH; Hess EV
    Lancet; 1980 Nov; 2(8204):1145. PubMed ID: 6107762
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of danazol in the MRL/lpr mouse model of autoimmune disease.
    Connolly KM; Stecher VJ; Snyder BW; Bohnet E; Potts GO
    Agents Actions; 1988 Aug; 25(1-2):164-70. PubMed ID: 3189043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic lupus erythematosus: two patients treated with danazol.
    Morley KD; Parke A; Hughes GR
    Br Med J (Clin Res Ed); 1982 May; 284(6327):1431-2. PubMed ID: 6805552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Danazol therapy in patients with immune cytopenias.
    Manoharan A
    Aust N Z J Med; 1987 Dec; 17(6):613-4. PubMed ID: 3447572
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment with danazol and plasma glucagon concentration.
    Williams G; Lofts F; Fuessl H; Bloom S
    Br Med J (Clin Res Ed); 1985 Oct; 291(6503):1155-6. PubMed ID: 3931833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term danazol therapy in autoimmune thrombocytopenia: unmaintained remission and age-dependent response in women.
    Ahn YS; Rocha R; Mylvaganam R; Garcia R; Duncan R; Harrington WJ
    Ann Intern Med; 1989 Nov; 111(9):723-9. PubMed ID: 2802430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Danazol in refractory autoimmune thrombocytopenic purpura (ATP). A new therapeutic sequence.
    Ambriz-Fernández R; Chávez-Sánchez G; Pizzuto-Chávez J; Morales-Polanco MR; Aviles-Miranda A
    Arch Invest Med (Mex); 1985; 16(3):295-304. PubMed ID: 3833096
    [No Abstract]   [Full Text] [Related]  

  • 16. The use of danazol in the management of chronic immune thrombocytopenic purpura.
    McVerry BA; Auger M; Bellingham AJ
    Br J Haematol; 1985 Sep; 61(1):145-8. PubMed ID: 4052322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Danazol in the treatment of systemic lupus erythematosus: a qualitative systematic review.
    Letchumanan P; Thumboo J
    Semin Arthritis Rheum; 2011 Feb; 40(4):298-306. PubMed ID: 20541792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of familial lupus erythematosus-like disease and hereditary angio-oedema treated with danazol.
    Youinou P; Dorval JC; Cledes J; Leroy JP; Miossec P; Masse R
    Br J Dermatol; 1983 Jun; 108(6):717-22. PubMed ID: 6602623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Danazol for systemic lupus erythematosus with refractory autoimmune thrombocytopenia or Evans' syndrome.
    Cervera H; Jara LJ; Pizarro S; Enkerlin HL; Fernandez M; Medina F; Fraga A; Miranda JM
    J Rheumatol; 1995 Oct; 22(10):1867-71. PubMed ID: 8991983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exacerbation of a lupus-erythematosus-like syndrome during treatment of non-C1-esterase-inhibitor-dependent angioedema with danazol.
    Fretwell MD; Altman LC
    J Allergy Clin Immunol; 1982 Mar; 69(3):306-10. PubMed ID: 6977562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.